Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Non-cash Items (2021 - 2025)

Historic Non-cash Items for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $6.6 million.

  • Kiniksa Pharmaceuticals International's Non-cash Items fell 1267.12% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 1267.12%. This contributed to the annual value of $7.7 million for FY2024, which is 442.73% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Non-cash Items stood at $6.6 million for Q3 2025, which was down 1267.12% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Non-cash Items ranged from a high of $54.7 million in Q4 2023 and a low of $4.4 million during Q1 2021
  • Its 5-year average for Non-cash Items is $10.7 million, with a median of $7.0 million in 2023.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Non-cash Items soared by 11833.14% in 2022, and later tumbled by 8595.68% in 2024.
  • Kiniksa Pharmaceuticals International's Non-cash Items (Quarter) stood at $14.9 million in 2021, then skyrocketed by 118.33% to $32.6 million in 2022, then skyrocketed by 67.47% to $54.7 million in 2023, then crashed by 85.96% to $7.7 million in 2024, then dropped by 13.37% to $6.6 million in 2025.
  • Its Non-cash Items was $6.6 million in Q3 2025, compared to $7.2 million in Q2 2025 and $7.8 million in Q1 2025.